Crypto tycoon Zhao Changpeng plans comeback after Trump pardon: analysts
The Chinese-born Canadian entrepreneur, widely known as CZ, received a pardon after he pleaded guilty to breaking US anti-money-laundering laws […]
October 24, 2025
Navigating Challenges With Strong Revenue Growth
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, is navigating a
Trump Crypto Partner Alt5 Sigma Suspends CEO With No Explanation After Stock Crashes 74%
Topline Alt5 Sigma, which bet its future on a Trump family crypto venture and has since seen its stock price
Exploring A 106.66% Potential Upside With Solid Buy Ratings
LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, particularly in health information services, has captured the attention
Altcoins Fall Sharply, This Under $1 Crypto Keeps Rising
PRESS RELEASE Published October 24, 2025 The cryptocurrency market weakened on October 21 after several sessions of recovery. Bitcoin dropped
59% Potential Upside Fuels Investor Excitement
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is increasingly capturing the attention of savvy investors, thanks to its remarkable growth potential and
Russia Moves to Legalize Cross-Border Crypto While Tightening Domestic Oversight
15h05 ▪ 4 min read ▪ by Ifeoluwa O. Summarize this article with: ChatGPTPerplexityGrok Russia, recently recognized as Europe’s leading
Insiders Find Solace Selling US$530m In Stock With CoreWeave’s Price Down 13%
By selling US$530m worth of CoreWeave, Inc. (NASDAQ:CRWV) stock at an average sell price of US$73.62 over the last year,
Crypto treasuries siphon $800B from altcoins, and it might be ‘forever’ — TradingView News
Despite growing expectations of an imminent altcoin season, industry insiders are pointing to capital flowing back into Bitcoin and corporate
Nearly 100% Upside Potential Amid Biotech Innovation
Verastem, Inc. (NASDAQ: VSTM), a pioneering biopharmaceutical company, presents a compelling case for investors seeking exposure to the biotechnology sector,